Biomarker Discovery | Autoantibody Profiling

Discover the power of autoantibodies

Sengenics is an industry leader in developing cutting-edge, high-throughput tools for precise autoantibody profiling from just a drop of blood.

Autoantibodies have versatile applications across a broad spectrum of diseases, from identifying protein effectors to predicting adverse events. Highly complementary to other omics datasets, autoantibody profiling is a key component in the precision medicine toolkit, transforming patient profiles into actionable insights.

Talk to an Expert

Autoantibodies as Biomarkers

Explore why autoantibodies are excellent clinical biomarkers across diverse health conditions, from autoimmune diseases to neurological disorders.

Read White Paper

Citrullination and Inflammation

Learn about citrullination, a post-translational modification linked to inflammation and cellular stress, and its implications for disease diagnosis and therapeutic development.

Read White Paper

Autoantibodies in Cancer

Discover how autoantibody profiling can be harnessed for cancer precision medicine, from detecting disease well before symptoms to guiding vaccine and drug development.

Read White Paper

Excellence at Every Step

Biologically relevant

Measure interactions confidently with assays using full-length, correctly folded proteins

Precise profiling

Trust your data’s accuracy with superior reproducibility, picomolar sensitivity, and wide dynamic range

Comprehensive support

Prioritize your core activities while our experts generate the data you need, from study design to data analysis

Flexible options

Select from custom or pre-set panels featuring 1800+ proteins across diverse classes and pathways

Worldwide access

Send your samples to Sengenics or one of our certified service providers near you for expert processing and analysis

Widely adopted

Join top pharma companies and academic institutions gaining actionable insights into disease

See the Science

On-Demand Webinar

Serum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups

Recorded June 18, 2024

In this webinar, Dr. Sung presents his research exploring the immunological differences between rheumatoid arthritis (RA) subgroups.

Learn how 1600+ IgG autoantibodies from serum were screened, yielding biologically relevant and immunologically significant insights.
Discover the distinct autoantibody profiles in RA patients and their correlation with the Clinical Disease Activity Index, a measure of disease activity.
Understand which proteins and their associated biological processes were predominantly targeted by these autoantibodies.
Examine how autoantibody biomarker signatures can enhance patient stratification and diagnostic accuracy in RA.

This webinar is relevant to anyone involved in biomarker research or interested in the applications of autoantibody biomarkers.

Watch Now

Jaeyun Sung, PhD
Senior Associate Consultant,
Assistant Professor,
Mayo Clinic

Protein Folding Matters

Discover the Sengenics solution for accurately profiling autoantibodies in a short, 1-minute video.

Play Video

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

Design and development by RainCastle Communications.

Fast-track your journey to precision
diagnostics and streamlined drug
development

Discover the power of autoantibodies

Autoantibodies as Biomarkers

Citrullination and Inflammation

Autoantibodies in Cancer